Form 8-K - Current report:
SEC Accession No. 0001494650-24-000140
Filing Date
2024-10-08
Accepted
2024-10-07 18:34:59
Documents
17
Period of Report
2024-10-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K optn-20241007.htm   iXBRL 8-K 44515
2 EX-10.1 kohlerpaul_employmentagree.htm EX-10.1 178272
3 EX-99.1 a20241007optinosecfo.htm EX-99.1 22613
7 image_0a.jpg GRAPHIC 31041
8 optn-20241007_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-24-000140.txt   488956

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20241007.xsd EX-101.SCH 1904
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20241007_lab.xml EX-101.LAB 21689
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20241007_pre.xml EX-101.PRE 12525
19 EXTRACTED XBRL INSTANCE DOCUMENT optn-20241007_htm.xml XML 2722
Mailing Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067
Business Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

EIN.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 241358870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)